Related Experiment Video
Updated: Jun 11, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
A Paradoxical Tumor Antigen Specific Response in the Liver
Rajiv Trehan1, Xiao Bin Zhu1, Patrick Huang1
1Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Liver tumors harbor abundant but exhausted CD8+ T cells. Extrahepatic tumors promote an intermediate cell population that inhibits anti-tumor immunity, facilitating liver metastasis and reducing immunotherapy efficacy.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Functional tumor-specific CD8+ T cells are critical for anti-tumor immunity and immunotherapy success.
- Liver metastases exhibit higher numbers of CD8+ T cells compared to other sites, but these cells often display an exhausted phenotype.
Purpose of the Study:
- To investigate the phenotype and function of CD8+ T cells in liver tumors.
- To elucidate the mechanisms by which extrahepatic tumors promote liver metastasis and impair anti-tumor immunity.
Main Methods:
- Murine tumor models and patient-derived single-cell RNA sequencing (scRNA-seq) data analysis.
- High-dimensional multi-omic analysis integrating proteomic CODEX and scRNA-seq.
- Functional CD8+ T cell depletion experiments and Spp1 knockout mouse models.
Main Results:
- Liver tumor-infiltrating CD8+ T cells are abundant yet exhausted, failing to control tumor growth locally but effective against distant tumors.
- SPP1+ macrophages interact with CD8+ T cells in profibrotic liver regions, contributing to T cell exhaustion.
- Spp1 deficiency ameliorates T cell exhaustion and reduces liver tumor growth.
- Extrahepatic signaling induces an intermediate cell (IC) population in the liver, characterized by specific surface markers, which predicts liver metastasis.
Conclusions:
- Extrahepatic tumors create a pro-metastatic liver microenvironment by inducing an IC population that suppresses CD8+ T cell function.
- This mechanism contributes to liver metastasis and may limit the effectiveness of immune checkpoint inhibitor therapy in liver cancer.
More Related Videos
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024